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Purpose: The aim of this study was to evaluate the tissue stiffness of solid pancreatic lesions by 
using acoustic radiation force impulse (ARFI) elastography to differentiate benign from malignant 
pancreatic lesions.
Methods: ARFI elastography was performed in 26 patients who had 27 focal solid pancreatic 
lesions, including 8 benign lesions (mass-forming pancreatitis, 5; autoimmune pancreatitis, 3) 
and 19 malignant lesions (pancreatic adenocarcinoma, 16; metastasis from colorectal cancer, 2; 
malignant neuroendocrine tumor, 1). On the elastographic images of virtual touch tissue imaging 
(VTI), the echogenicity of the mass was categorized on a 5-grade scale. On the elastographic 
image of virtual touch tissue quantification (VTQ), the shear wave velocities (SWVs) of the lesion 
and surrounding parenchyma were measured.
Results: On the VTI images, the mean echogenicity score of the malignant lesions (3.7±1.0) was 
higher than that of the benign lesions (3.1±0.4; P=0.023). On the VTQ images, there were no 
statistical differences in the mean SWV between the benign (2.4±1.1 m/sec) and malignant 
(3.3±1.0 m/sec) lesions (P=0.101). However, the mean SWV difference values between the 
lesion and background parenchyma of the malignant lesions (1.5±0.8 m/sec) were higher than 
those of the benign lesions (0.4±0.3 m/sec; P=0.011).
Conclusion: ARFI elastography can determine the relative stiffness between a lesion and the 
background pancreatic parenchyma using VTI and VTQ, which is helpful in the differentiation 
between benign and malignant solid pancreatic lesions.
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ORIGINAL ARTICLE
Introduction
Ultrasonography (US) is a useful imaging modality for detection of focal pancreatic lesions. To 
characterize the lesions and determine malignancy, however, its role is limited; differentiation between 
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pancreatic cancer and mass-forming pancreatitis is challenging in 
many cases encountered in daily practice [1].
Elastography is a method for visualizing the elastic properties 
of tissue using ultrasound. This technology is divided into strain 
elastography to visualize the tissue deformation induced by external 
compression and shear wave elastography, which estimates the 
shear wave velocity generated using an acoustic push pulse [2]. 
Initial clinical applications of strain elastography have focused 
on superficial organs such as the breast, thyroid, and prostate. 
Many investigators have reported that elastography was helpful in 
differentiating between benign and malignant tumors and that it 
improved the specificity of the US [3-9]. 
Recently, acoustic radiation force impulse (ARFI) elastography 
has emerged as a new method for measuring the stiffness of deep 
tissue, making transcutaneous elastography of the pancreas more 
feasible as a result. Pancreatic applications of US elastography are 
relatively recent because of the difficulty in pressing the pancreas, 
which is located deep in the body. Endoscopic ultrasound (EUS) 
elastography is rather widely used for diagnostic purposes, and its 
effectiveness has been well documented [10-14]. Transcutaneous 
elastography of the pancreas has been discussed in several studies, 
but the efficacy of this technique has yet to be proven due to small 
sample sizes [15,16].
Pancreatic ductal adenocarcinoma is a firm mass, owing to the 
presence of fibrosis and a marked desmoplastic reaction [17]. Focal 
pancreatitis is also characterized by fibrosis but manifests with 
varying patterns according to the degree of atrophy and fibrosis 
of the lesion and adjacent parenchyma, depending on the acute 
or chronic stages. We hypothesized that elastography could be 
helpful in the differentiation of solid pancreatic lesions based on 
these histological characteristics. This study was aimed at evaluating 
the feasibility of ARFI elastography in differentiating benign from 
malignant solid pancreatic masses.
Materials and Methods
Patients
Permission from the Institutional Review Board (IRB) at our 
institution was granted to perform this review and analysis. The IRB 
waived the requirement for informed consent for this retrospective 
study. We retrospectively identified a total of 29 patients with focal 
solid pancreatic lesions who underwent ARFI elastography, with the 
diagnosis confirmed by histopathologic examinations after surgical 
resection or US-guided biopsy between May 2010 and March 2013 
by searching the medical databases. Three patients were excluded 
from the study due to technical failure from the patient’s inability to 
hold his or her breath properly.
Thus, our study population consisted of a total 26 patients (16 
males, 10 females). There were 27 lesions included in this study 
because one patient with mass-forming pancreatitis had two lesions. 
The pancreatic lesions included 8 benign lesions (mass-forming 
pancreatitis, 5; autoimmune pancreatitis, 3) and 19 malignant 
lesions (pancreatic adenocarcinoma, 16; metastasis from colorectal 
cancer, 2; malignant neuroendocrine tumor, 1). The mean age of the 
benign group and malignant group was 62 years (range, 51 to 81 
years) and 57 years (range, 37 to 75 years), respectively. 
Image Acquisition and Analysis 
All of the patients underwent conventional abdominal US and 
ARFI scans, and a radiologist (JHC) with 17 years' experience of 
abdominal US conducted all of the examinations. Siemens Acuson 
S2000 CDFI (Siemens, Mountain View, CA, USA) and ARFI imaging 
technology using a 4C1 convex array probe with a frequency of 2.0-
4.0 MHz were used in this study. Two kinds of ARFI elastography 
imaging studies, virtual touch tissue imaging (VTI) and virtual touch 
tissue quantification (VTQ), were performed and analyzed to assess 
the qualitative and quantitative lesion stiffness. When ARFI scanning 
was performed, the patient was asked to stop breathing for a 
moment for accurate and reproducible estimation. 
A VTI image visualizes the relative stiffness in the selected region 
of interest (ROI) with a gray-scale map. It uses a dual imaging 
screen with the left screen showing the B-mode image and the 
right screen showing the elastographic image. Tissue softness is 
portrayed by high echogenicity and hardness by low echogenicity 
[18,19]. In this study, the echogenicity of the lesion was scored on 
a 5-grade scale to determine lesion stiffness relative to the adjacent 
pancreatic parenchymal echogenicity: very hyperechoic (1 point, 
white), hyperechoic (2 points, light gray), isoechoic (3 points, gray), 
hypoechoic (4 points, patchy black), and very hypoechoic (5 points, 
dark black). A higher score denotes stiffer tissue (Fig. 1). All of the 
results were agreed upon by two radiologists who were blinded to 
the pathological and clinical data.
The VTQ image measures the shear wave velocity (m/sec) of 
the lesion by placing the ROI within the lesion tissues. The stiffer 
the tissue, the faster the shear waves propagate. Thus it provides 
numerical measurements about tissue elasticity properties [18, 
19]. The value is objective and reproducible as a quantitative 
indicator. Therefore, it can be used for comparison with the tissue 
elasticity properties of other patients, without taking the hardness 
of adjacent parenchyma into consideration [20]. In this study, the 
shear wave velocity (m/sec) was measured in the ROI of the lesion 
and surrounding parenchyma five times each. The mean value (±SD) 
was calculated from a total of three scores excluding the highest 
and lowest scores. The ROI was located within the mass, without Min Kyoung Park, et al.
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including any vessels or biliary structures. The necrotic, cystic, 
hemorrhagic, or calcified portion should not be included in the ROI. 
The surrounding pancreatic parenchyma was also measured, with 
the ROI located 2-3 cm from the focal lesion, taking care not to 
include any vessels or biliary structures.
Statistical Analysis
The statistical analysis was performed using SPSS ver. 12.0 (SPSS 
Inc., Chicago, IL, USA). The mean sizes of the benign and malignant 
lesions were compared with each other with the use of a t-test. 
Comparisons of the mean echogenicity score in the VTI image, mean 
shear wave velocitie (SWV, m/sec) of the lesion and surrounding 
Table 1. Comparison of the acoustic radiation force impulse values in the benign and malignant groups 
Variable Benign Malignant P-value
Mean echogenicity score 3.1±0.4 (2-4) 3.7±1.0 (2-5) 0.023
Mean SWV of the mass (m/sec) 2.4±1.1 (0.9-3.7) 3.3±1.0 (1.3-4.8) 0.101
Parenchymal mean SWV (m/sec) 2.11±0.8 (1.2-3.4) 1.55±0.6 (0.9-3.8) 0.121
Mean SWV difference value
a) (m/sec) 0.4±0.3 (0.1-1.6) 1.5±0.8 (0.3-3.4) 0.011
SWV, shear wave velocity.
a) Mean SWV difference value (m/sec)=mean SWV of the mass (m/sec)-parenchymal mean SWV (m/sec).
A B
Fig. 1. Representative virtual touch tissue imaging (VTI) for each echogenicity score. 
A. On a VTI image, a score 2 lesion appears to have a light gray color. B. On a VTI image, a score 3 lesion has a gray color. C. On a VTI image, 
a score 4 lesion appears to have a patchy black color. D. On a VTI image, a score 5 lesion appears dark black.
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parenchyma, mean SWV difference value (=mean SWV of the lesion-
parenchymal mean SWV, m/sec) in the VTQ image between benign 
and malignant lesions were performed by a Mann-Whitney U-test. 
Differences were considered significant at P<0.05. Correlations 
between the SWV and lesion size were tested using Spearman’s 
correlation coefficient.
Results
The mean maximum diameter of the benign group and malignant 
group was 2.5 cm (range, 1.1 to 10.3 cm) and 2.9 cm (range, 1.2 to 
7.4 cm), respectively. There was no significant difference in the mean 
maximum diameter between the benign and malignant liver lesions 
(P=0.303). 
On the VTI images, the mean echogenicity score of the malignant 
lesions (3.7±1.0) appeared higher compared with that of the benign 
lesions (3.1±0.4; P=0.023) (Table 1, Figs. 2-4). On the VTQ images, 
there were no statistical differences in the mean SWV between the 
benign (2.4±1.1 m/sec) and malignant (3.3±1.0 m/sec) lesions 
(P=0.101) (Table 1, Fig. 5A). However, the mean SWV difference 
values between the lesion and background parenchyma of the 
malignant lesions (1.5±0.8 m/sec) were higher than those of the 
benign lesions (0.4±0.3 m/sec; P=0.011) (Table 1, Figs. 3, 4, 5B). 
The mean ARFI value of the extra-lesional pancreatic parenchyma 
was 1.78 m/sec. The malignant group (1.55±0.6 m/sec) showed 
a higher ARFI value than the benign groups (2.11±0.8 m/sec), 
although the difference was not statistically significant (Table 1). 
The SWV was independent of lesion size (Spearman correlation 
coefficient, -0.178; P=0.416). 
Discussion
Regarding the transcutaneous or EUS elastography in the 
assessment of focal pancreatic lesions, some earlier studies 
analyzing elastographic patterns were rather inconclusive due to 
the subjectivity of the interpretation of the color map and a lack 
of reliability and consistency [10,11,13,15]. On the other hand, 
Fig. 3. A 62-year-old woman with focal pancreatitis. 
A. On a conventional B-mode image, the lesion appears as a hypoechoic mass (left image). On a virtual touch tissue imaging elastographic 
image, the lesion shows a stiffness similar to the surrounding pancreatic parenchyma (echogenicity score, 3) (right image). The shear wave 
velocity of the lesion and surrounding pancreatic parenchyma was 2.08 m/sec and 2.02 m/sec, respectively. B. Axial computed tomography 
scan shows an ill-defined hypodense mass in the pancreatic head region.
A B
Fig. 2. Comparison of the virtual touch tissue imaging values of 
the benign and malignant groups. The mean echogenicity score for 
the benign group and malignant group were 3.1±0.4 and 3.7±1.0, 
respectively (P=0.023). 
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Itokawa et al. [21] asserted that strain elastography during EUS 
effectively determined the strain ratio of the pancreatic cancer to be 
significantly higher than that of mass-forming pancreatitis in a study 
using quantitative second-generation strain elastography followed 
by a multicenter study showing high accuracy of about 80%-90% 
[22]. However, EUS is invasive and not easy for the patient because 
sedation is required. In addition, there are some technical limitations 
because it is difficult to control the compression of a target tissue 
by endoscopic probe or to exclude the very soft or hard tissues of 
adjacent structures like the heart, major vessels, and vertebrae in a 
selected ROI. Furthermore, undesirable results can be expected when 
a lesion is larger than 3 cm or deeply seated and can be affected by 
motion artifacts such as those from breathing or the heartbeat [13].
Several studies on transcutaneous elastography of the pancreas 
have been published in the recent literature but with limited validity. 
Uchida et al. [15] reported that the lesion detection rate and 
diagnostic rate could be improved to over 90% by the combined use 
of B-mode and elastographic images, compared to using B-mode 
images alone. Kawada et al. [16] analyzed the elastographic 
patterns of three benign masses and 30 malignant masses in terms 
of the predominant color and color distribution and reported that 
90% of ductal adenocarcinoma cases, particularly all of them over 
25 mm in size, were characterized by blue color patterns and 72% 
of them showed a heterogeneous distribution. In their study, the 
mean strain ratio of the ROI placed over a mass to the ROI over the 
adjacent parenchyma was 4.15 for the benign masses and 12.16 for 
the malignant masses, although the difference was not statistically 
significant (P=0.234), which might be limited by the small number 
of benign lesions [16].
ARFI is a kind of shearwave elastography. It provides information 
about tissue stiffness by focusing high-intensity acoustic pulses on 
a target area using a conventional ultrasound probe to propagate 
shear waves and detect the tissue's response by using a tracking 
pulse emitted by numerous transmission channels [19]. It enables 
A B
Fig. 4. A 67-year-old woman with pancreatic adenocarcinoma. 
A. On a conventional B-mode image, the lesion appears as an ill-
defined hypoechoic mass (left image). On a virtual touch tissue 
imaging elastographic image, the lesion appears to be stiffer than 
the surrounding pancreatic parenchyma (echogenicity score, 4; 
right image). The shear wave velocity of the lesion and surrounding 
pancreatic parenchyma was 4.85 m/sec and 2.23 m/sec, respectively. 
B, C. Axial computed tomography scans show an ill-defined 
hypodense mass in the pancreatic body, distal p-duct dilatation, and 
parenchymal atrophy, suggesting pancreatic cancer. 
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operators to measure tissue elasticity in the desired region by 
monitoring real-time anatomical details provided by the B-mode 
image, as well as perform quick assessment. Since it does not use 
external compression, image acquisition is less affected by the 
operator, including the degree of force the operator uses to press 
the probe, and allows quantitative measurement of tissue, including 
elasticity and speed. High reproducibility is another advantage 
of ARFI [20,23]. In addition, transcutaneous elastography of the 
pancreas with ARFI scanning is less invasive than EUS and does not 
require sedation of the patient during examination. It is also easy 
to use without a delayed setup period during conventional B-mode 
ultrasonography [24,25].
According to earlier studies investigating the role of ARFI, 
the mean ARFI value for normal pancreatic parenchyma was 
approximately 1.28 to 1.40 m/sec [26,27]. In the present study, 
the mean ARFI value for extra-lesional pancreatic parenchyma was 
1.78 m/sec; and the benign group showed a higher ARFI value than 
the malignant group, although the difference was not statistically 
significant. Although pancreatic cancer is a firm mass characterized 
by high ARFI values, the distribution of ARFI values varied among 
studies and the number of studies was limited [28]. Chronic 
pancreatitis, the most important disease entity for differential 
diagnosis from pancreatic adenocarcinoma, is also commonly 
accompanied by fibrosis and calcification, leading to high ARFI 
values [26,29]. 
In the present study, the relative stiffness of a lesion to the 
adjacent parenchyma was significantly higher in the malignant 
group than in the benign group on both VTI and VTQ images. The 
stiffness of extra-lesional pancreatic parenchyma was also higher 
in the benign group than the malignant group. This means that 
fibrosis and calcification that developed not only in the lesion but 
also in the surrounding parenchyma in the benign group resulted in 
higher stiffness than would be found in normal parenchyma, making 
the difference in stiffness between the lesion and surrounding 
parenchyma insignificant. Based on the results of the present study, 
because both pancreatic adenocarcinoma and mass-forming chronic 
pancreatitis are characterized by hardness, the relative stiffness of a 
lesion to its adjacent parenchyma can be expected to provide more 
accurate information than the absolute ARFI value of a lesion. 
This study has several limitations. First of all, a smaller number 
of subjects with benign lesions, that is, mass-forming pancreatitis, 
than those with pancreatic adenocarcinoma made it difficult to 
generalize the results of the study. Further research needs to 
include a larger number of patients with benign lesions. Regarding 
the technical limitations, ARFI is a static image that is sensitive to 
motion during measurement; thus it is not effective in examining 
patients with a lesion near a large blood vessel and those who have 
difficulty sustaining a breath hold. Five-time sampling would not be 
enoughfor obtaining conclusive results.
In conclusion, ARFI elastography identified relative stiffness values 
between the lesion and background pancreatic parenchyma using 
VTI and VTQ, which could be helpful in differentiating malignant 
tumors from benign inflammatory lesions, although there was a 
considerable degree of overlap between the ARFI values of the 
benign and malignant lesions.
Fig. 5. Comparison of virtual touch tissue quantification values of the benign and malignant groups. 
A. The mean shear wave velocity (SWV; m/sec) for the benign group and malignant group were 2.4±1.1 and 3.3±1.0, respectively (P=0.101). 
B. The mean shear wave velocity difference value (SWV of lesion-SWV of normal parenchyma) for the benign group and malignant group 
were 0.4±0.3 and 1.5±0.8, respectively (P=0.011).
A B
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